Skip to content

Risk profile for stage 3 medication-related osteonecrosis of the jaw: a retrospective study based on medical records

Risk profile for stage 3 medication-related osteonecrosis of the jaw: a retrospective study based on medical records

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000032428
Enrollment
Unknown
Registered
2020-04-27
Start date
2020-05-01
Completion date
Unknown
Last updated
2020-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Medication-related osteonecrosis of the jaw

Interventions

stage 2 MRONJ:N/A
stage 3 MRONJ:N/A

Sponsors

Shanghai Ninth People's Hospital, Collage of Stomatology, Shanghai Jiaotong University School of Medicine; National Clinical Research Center of Oral Disease
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 89 Years

Inclusion criteria

Inclusion criteria: 1. All included patients were diagnosed with MRONJ. (1) current or previous treatment with a BMA or angiogenic inhibitor; (2) exposed bone or bone that can be probed through an intraoral or extraoral fistula in the maxillofacial region and that has persisted for longer than 8 weeks, and (3) no history of radiation therapy to the jaws or metastatic disease to the jaws. 2. Patients with stage 2 or stage 3 were included. (1) stage 2: Stage 2: Exposed and necrotic bone or fistulas that probe to bone associated with infection as evidenced by pain and erythema in the region of exposed bone with or without purulent drainage. (2) stage 3: Exposed and necrotic bone or a fistula that probes to bone in patients with pain, infection, and one or more of the following: exposed and necrotic bone extending beyond the region of alveolar bone (ie, inferior border and ramus in mandible maxillary sinus, and zygoma in maxilla) resulting in pathologic fracture, extraoral fistula, oral antral or oral nasal communication, or osteolysis extending to the inferior border of the mandible or sinus floor.

Exclusion criteria

Exclusion criteria: Patients with developmental maxillofacial anomalies, previous radiation in the head and neck area and jaw bone tumors were excluded from the study.

Design outcomes

Primary

MeasureTime frame
demographic: age, gender, smoking, cancer types, osteoporosis, general diseases, tooth extraction, denture use, periodontal disease, chemotherapy use, targeted drugs use, endocrine drugs use, immune suppressive drugs;lesion location;radiological data (sequestrum size and bone density of lesion);

Countries

China

Contacts

Public ContactShaoyi Wang

Department of Oral Surgery, Shanghai Ninth People's Hospital affiliated to Shanghai Jiaotong University School of Medicine

wangshaoyi163@aliyun.com+86 13917179943

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 19, 2026